Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Approval based on data from REAL AF Registry, demonstrating value of real-world evidence
Stay updated with breaking news from Density Mapping Catheter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval based on data from REAL AF Registry, demonstrating value of real-world evidence
/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced that several...
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias
/PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, today announced the release of the OCTARAY™ Mapping Catheter with TRUEref™...
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias1,2† IRVINE,